Iterum Therapeutics Cash from Investing (TTM) Insights

Iterum Therapeutics PLC (ITRM)

1.57 +0.02 (+1.29%) USD | NASDAQ | Apr 25, 16:00

1.57 0.00 (0.00%) After-Hours: 20:00

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2017. Upgrade now.

Date	Value
December 31, 2023	23.34M
September 30, 2023	14.19M
June 30, 2023	29.68M
March 31, 2023	9.47M
December 31, 2022	13.96M
September 30, 2022	5.113M
June 30, 2022	-5.799M
March 31, 2022	-11.08M
December 31, 2021	-54.60M
September 30, 2021	-50.13M
June 30, 2021	-55.07M
March 31, 2021	-33.93M
December 31, 2020	-0.011M

Date	Value
September 30, 2020	-0.013M
June 30, 2020	0.021M
March 31, 2020	5.011M
December 31, 2019	40.10M
September 30, 2019	68.85M
June 30, 2019	51.05M
March 31, 2019	17.08M
December 31, 2018	-8.658M
September 30, 2018	-30.96M
June 30, 2018	-16.82M
March 31, 2018	-21.71M
December 31, 2017	-31.59M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-55.07M

Minimum

Jun 2021

68.85M

Maximum

Sep 2019

2.639M

Average

5.011M

Median

Mar 2020

Cash from Investing (TTM) Benchmarks